Literature DB >> 1547502

Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains.

B M Chan1, P D Kassner, J A Schiro, H R Byers, T S Kupper, M E Hemler.   

Abstract

To characterize VLA alpha subunit cytoplasmic domain functions, unaltered alpha 2 cDNA (called X2C2) and two chimeric cDNAs (called X2C5 and X2C4) were constructed with extracellular alpha 2 domains and cytoplasmic alpha 2, alpha 5, and alpha 4 domains respectively. Upon transfection into rhabdomyosarcoma (RD) cells, each construct yielded comparable expression levels, immunoprecipitation profiles, and avidity for collagen and laminin. However, while RDX2C2 and RDX2C5 transfectants mediated collagen gel contraction, RDX2C4 and a mock transfectant (RDpF) did not. Conversely, only RDX2C4 cells (but not RDX2C2 or RDX2C5) showed enhanced cell migration on collagen and laminin compared with RDpF cells. This indicates markedly differing roles for integrin alpha subunit cytoplasmic domains in post-ligand binding events. Furthermore, stable exertion of physical force (collagen gel contraction) may involve fundamentally different cellular machinery than the transient adhesion occurring during cell migration. Finally, these findings provide insight into a functional flexibility perhaps resulting from multiple integrins binding to identical ligands.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547502     DOI: 10.1016/0092-8674(92)90077-p

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  85 in total

1.  Collagen receptor control of epithelial morphogenesis and cell cycle progression.

Authors:  M M Zutter; S A Santoro; J E Wu; T Wakatsuki; S K Dickeson; E L Elson
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro.

Authors:  J Varani; D Spearman; P Perone; S E Fligiel; S C Datta; Z Q Wang; Y Shao; S Kang; G J Fisher; J J Voorhees
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Apoptosis in v-myc-transfected MSU-1.1 fibroblasts is induced by cell-matrix contact and differs from that of normal dermal fibroblasts.

Authors:  S Niland; A Cremer; K Herzhoff; B V Nusgens; C M Lapière; T Krieg; B Eckes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

4.  alpha4beta1 integrin regulates lamellipodia protrusion via a focal complex/focal adhesion-independent mechanism.

Authors:  Karen A Pinco; Wei He; Joy T Yang
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

5.  Integrin CD11a cytoplasmic tail interacts with the CD45 membrane-proximal protein tyrosine phosphatase domain 1.

Authors:  Xin Geng; Ren-Hong Tang; S K Alex Law; Suet-Mien Tan
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

6.  Enhancement of activation-induced cell death by fibronectin in murine CD4+ CD8+ thymocytes.

Authors:  E Takayama; T Kina; Y Katsura; T Tadakuma
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

7.  The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.

Authors:  R Alon; P D Kassner; M W Carr; E B Finger; M E Hemler; T A Springer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

8.  Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells.

Authors:  S Klein; F G Giancotti; M Presta; S M Albelda; C A Buck; D B Rifkin
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

9.  Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.

Authors:  L Wu; J A Bernard-Trifilo; Y Lim; S-T Lim; S K Mitra; S Uryu; M Chen; C J Pallen; N-Kv Cheung; D Mikolon; A Mielgo; D G Stupack; D D Schlaepfer
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

10.  Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions.

Authors:  R A Sobel; J R Hinojoza; A Maeda; M Chen
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.